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Summary.-Mice immunologically deprived by thymectomy, cytosine arabinoside
treatment and whole-body irradiation were used to study the growth of human
tumours as xenografts. 10/16 melanoma biopsies, 4/13 ovarian carcinoma biopsies
and 3/6 uterine cancer biopsies grew as serially transplantable xenograft lines.
The tumour lines were studied through serial passages by histology, histo-
chemistry, electron microscopy, chromosome analysis, immune fluorescence, growth
rate measurement and mitotic counts. They retained the characteristics of the tu-
mours of origin, with the exception of loss of pigmentation in two melanomas,
histological dedifferentiation in the uterine carcinomas, and increased mitotic
frequency and growth rate in some melanomas.
It was concluded that this type of animal preparation is as useful as alternative
methods of immunological deprivation, or as athymic nude mice, for the growth of
human tumour xenografts, at least for some experimental purposes.
THERE is increasing interest in the
growth of human tumours and xenografts
in immunologically deprived mice, and in
the use ofthese tumours to investigate the
biology and therapy of human cancer.
Ample data show that a substantial pro-
portion of human tumours of some histo-
logical types may be grown in congenitally
athymic "nude" mice (Rygaard &
Povlsen, 1969; Second International
Workshop on Nude Mice, 1977) or in
normal mice deprived of T-lymphocyte
function by thymectomy combined with
irradiation, marrow reconstitution and/or
anti-lymphocyte serum (Castro, 1972;
Cobb & Mitchley, 1974; Berenbaum et al.,
1974).
Recently, in this laboratory, a new
method of "T-deprivation" has been
investigated. It has been found that the
lethal effects of 900 rad whole-body
irradiation may be prevented by treat-
ment of the mouse with cytosine arabino-
side (AraC) 200 mg/kg i.p. 2 days before-
hand (Millar et al., 1978). Mice may, there-
fore, be immune-deprived by thymectomy,
AraC pretreatment and irradiation, and
such mice have been shown to be receptive
of xenografts from an established labora-
tory line (Steel et al., 1978). We have in-
vestigated the establishment of a series of
malignant human melanomas, ovarian
carcinomas and uterine cancers in the
AraC-pretreated mouse. The resulting
tumours have been studied through serial
passage by growth rate measurement,
histology, histochemistry, electron micro-
scopy, karyotyping and immune fluores-
cence for human antigens.
The tumours were established in order
to investigate their chemosensitivity using
clonogenic assays for human tumour cells.
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The results ofthese studies will be reported
separately.
MATERIALS AND METHODS
Tumours.-Tumour tissue was obtained
during diagnostic and therapeutic surgical
procedures carried out at the Royal Marsden
Hospital. In addition, some subcutaneous
tumour deposits were removed specifically
forxenografting, eitherunderlocalanaesthesia
or while the patients were generally anaes-
thetized for other purposes. The patient's
fully informed consent was always obtained
for this procedure, and no complications
ensued.
Solid tumours were cut into cubes of 2 mm
in each dimension and implanted bilaterally,
s.c. into the flanks of immune-deprived mice,
usually within one week of irradiation.
Five or more mice were used for initial
implants when sufficient tissue was available.
Malignant effusions were concentrated by
centrifugation and 106 malignant cells were
injected i.m. into each mouse hind leg.
Tumours were subsequently passaged s.c. as
solid pieces, except for HX34 and HX49
which were passaged i.m. as cell suspensions.
New tumour implants were observed for
at least 3 months for signs oftumour growth,
and in this study a successful take was only
recorded when a tumour successfully grew in
the second passage.
Mice.-Male CBA/Ca/Lac mice bred at
the Institute of Cancer Research breeding
centre, Pollards Wood, were thymectomized
at 4 weeks old and treated with 900 rad
whole-body irradiation from a cobalt-60
source (30 rad/min) 3-6 weeks later. The
lethal effects ofthisirradiation wereprevented
by an i.p. injection of200 mg/kg AraC 2 days
before irradiation. The animals were kept in a
separate animal house, on heat-sterilised
bedding and given acidified water to prevent
multiplication of pseudomonads, a common
source of fatal septicaemia. Apart from occa-
sional outbreaks of such infection, over 90%
of each batch survived throughout the
experiments
Tumour growth rates. - Tumours were
measured for their largest and smallest super-
ficial diameters using Vernier calipers and the
volume of the tumours estimated from the
formula 7r/6 d3, where d is the mean diameter.
Medial growth rates were estimated at a
volume of 0 5 cm3 and a median time to
reach that volume was estimated for each
tumour.
Histology.-Tissues were fixed in formalin
or in Bouin's fixative and stained by haema-
toxylin and eosin. Melanomas were stained for
melanin with a Fontana silver impregnation
technique. Where the latter was negative,
frozen sections ofthe melanomas were stained
histochemically for the enzyme dopa oxidase,
part ofthe biosynthetic pathway for melanin.
(These special stains were kindly used for us
by Mrs Diana Mitchell of the Department of
Histopathology, Royal Marsden Hospital.)
Ascites tumours were examined as stained
smears and viewed under phase contrast.
Electron microscopy.-For examination by
electron microscopy, tumour tissue was fixed
in 2% glutaraldehyde for 1 h at 4°C and
post-fixed in 1% osmic acid. Both fixatives
were phosphate buffered (0-05M, pH 7-2-7.4)
and the osmolarity was adjusted to 350 mOs/l
withsucrose. Specimens werethendehydrated
with ethanol and embedded in epon/araldite.
Thin sections were then stained with uranyl
acetate and lead citrate and examined with a
Philips EM400 electron microscope.
Chromosomes.-Karyotyping of xenograft
tumours was performed by Miss Judith
Mills of this Institute. Cell suspensions were
incubated with colchicine (0 4 ,ug/ml for 2 or
3 h) transferred to hypotonic KCI solution
(0.56%) for 9 min and fixed in Clarke's
fixative (methanol 3: glacial acetic acid 1).
Immunofluorescence.-Sectionswerestained
for human antigens using a "sandwich"
immunofluorescent technique. A rabbit anti-
serum raised against human tumour cells was
obtained from Dr Douglas Darcy of the
Division of Immunology and a fluorescein-
conjugated goat antiserum (globulin fraction)
with specificity for rabbit globulin was ob-
taimied from Miles-Yeda Ltd. Both were
absorbed with mouse liver acetone powder
(Sigma Chemicals Ltd) for 2 h at 4°C (100
mg of powder in 1 ml of serum). The rabbit
antiserum wasdiluted 1:4 and the fluorescein
conjugate diluted 1:20 with Ham's F12
medium with 20% special bobby-calf serum
(Gibco).
Tumours were fixed in formalin or Bouin's
fixative and paraffin-embedded. Sections were
dewaxed in xylol and ethanol and covered
with rabbit anti-human serum for 30 min at
4°C. They were thoroughly washed in medium
and the fluorescein-conjugated goat anti-
rabbit globulin was added for 45 min at 4°C.
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TABLE I.-Human tumour xenografts (HX)
No. of
Site ofbiopsy samples
Subcutaneous mett 10
Melanoma Intradermal met
Melanoma Lymph node met
Papillary Peritoneal met
cystadenocarcinoma of ovary
Ovarian Ca Malignant ascites
Primary breast Ca Breast
Breast Ca Pleural effusion
Endometrial uterine Ca Primary Curettage
Mixed mesodermal Nodal deposit
uterine tumour
Endometrial uterine Ca Peritoneal met
Polygonal-cell Ca Peritoneal met
2
4
8
5
2
2
4
1
1
1
No ofHX
established
8
0
2
4
0
0
0
1
1
HX designations
(current no. ofpassages)
HX40 (6) HX41 (6)
HX42 (4) HX45 (5)
HX46 (8) HX47 (7)
HX50 (5) HX52 (2)
HX34*(18) HX56 (3)
HX60 (2) HX61 (2)
HX62 (2) HX63 (2)
HX51 (3)
HX44 (3)
1 HX54 (3)
1 HX49 (8)
*Established by D. Courtenay in this Department. The tumour biopsy was cultured in medium for a few
days before implantation into the mouse.
tmet =metastasis.
Sections were thoroughly washed, covered in
buffered glycerol and a cover slip and
examined under a fluorescence microscope.
Experiments were controlled using normal
mouse tissue, and non-specific binding was
excluded from each experiment.
RESULTS
Take rates (Table I)
Sixteen samplesofmetastatic malignant
melanoma from various biopsy sites were
implanted and 10 serially transplantable
lines were established. Small nodules
initially grew at the sites of implantation
of5 other tumours, but these subsequently
regressed completely having reached less
than 5 mm diameter. No clear relationship
was observed between xenograft take and
biopsy site, histology, or previous treat-
ment of the implanted tumours. In 4/6
samples which failed to grow, there was
insufficient material to graft into 5 mice so
that the take rate of fully adequate
biopsies would be 10/12.
Thirteen specimens of metastatic
ovarian cancers were implanted; 8 as solid
tumours and 5 as ascites. Four trans-
plantable lines were established, none
from ascites.
Six specimens of uterine cancer were
implanted and 3 established transplant-
able xenograft lines resulted. Four of the
specimens were obtained at curretage of
primary endometrial uterine carcinomas.
Only one xenograft line was established
from this source, but the curette specimens
were often too small and a higher take rate
might be anticipated with better selection
of biopsy material. A peritoneal meta-
stasis from a primary endometrial carcin-
oma grew well as a xenograft as did a
lymphnode deposit derived from a mixed
mesodermal uterine tumour.
Four specimens of breast cancer were
implanted as xenografts, 2 from primary
biopsies and 2 from pleural effusions. No
xenograft takes were observed after 6
months' observation.
A peritoneal deposit from a primary of
unknown origin grew well, to establish a
transplantable xenograft line, HX49.
HISTOLOGY AND HISTOCHEMISTRY
The histological appearance of the
xenograftedtumours wasingeneral similar
to the original biopsy material. Tumours
as xenografts grew with necrotic centres,
or columns of necrosis spread through the
tumour, and there appeared to be a gen-
eral reduction in the content of stromal
tissue in those tumours which contained
large quantities of stroma in situ, though
this could not be quantified precisely.
Histology
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The 4 ovarian carcinomas which were
successfully grown as xenografts were
papillary adenocarcinomas, and their com-
plex and readily recognizable appearance
was maintained, although only early
passages have so far been examined. The
2 endometrial uterine adenocarcinomas
were of a moderate degree of differentia-
tion in situ, and appeared similar in the
mouse in the first passage. However, with
serial passage there was a tendency to-
wards a less differentiated histological
appearance. The mixed mesodermal
uterine tumour metastasis from a lymph
HX
designation
34
40
41
42
45
46
47
50
52
56
serial passage in the newly established
HX34.
Secondly, the numbers of mitoses per
30 high-power microscopic fields were
counted to give an indication of mitotic
frequency (Table III). It can be seen that
there was a tendency for mitotic frequency
to increase with passage, and in HX34,
HX47 and HX56 this increase was more
than 5-fold. Most mitoses occurred in
tumour cells rather than stromal cells, and
the increased number of mitoses did not
appear to be explained by a reduction in
the number of stromal cells in each field.
TABLE II.-Pigmentation of melanoma xenografts
Original biopsy Xenograft
-
A .Pi-
Dopa Passage Dopa a
Melanin oxidase No. Melanin oxidase
+ <<5 + D
+
+
0
0
0
+
0
>5 0
N2 +
N5 0
1 +
2 +
4 0
5 0
1-6 +
1 0
1-3 +
1-7 0
1-3 +
1-4 0
1-2 +
1-2 0
+ D
0
.gmentation
Lfter serial
passage
)ecreased
)ecreased
)ecreased
No change
No change
No change
No change
No change
No change
No change
No change
+ positive stain; 0 negative stain. Blanks indicate no test performed.
N: re-established after storage in liquid N2-
node had the histological appearance of
an osteogenic sarcoma, which was repro-
duced in the xenograft.
The melanoma xenografts closely repre-
sented the cytological features of their
tumours of origin and two aspects oftheir
histology were examined in detail. Pig-
mentation was assessed by specific stain-
ing, and the results are shown in Table II.
Eight tumours showed no change in pig-
mentation, but HX34 and HX40 showed
loss of pigmentation with serial passage,
though they retained the dopa oxidase
enzyme system. HX34 was re-established
from material stored in liquid N2 and
again was pigmented in early passages.
However, pigmentation decreased with
Ultrastructure
Two melanoma xenografts, HX41 and
HX47 and axenograftfrom adisseminated
TABLE III.-Mitoticfrequency ofmelanoma
xenografts
No. of mitoses in 30 high-power fields
r <-A
HX
34
40
41
42
45
47
50
52
56
Original
biopsy
7
13
19
14
29
13
26
34
6
Xenograft (passage number)
,~~~~~
32 (3) 53 (13) 81 (16)
41 (1) 47 (2) 54 (4)
32 (1) 41 (2) 19 (3)
28 (1) 53 (2)
59 (1)
72 (1) 80 (2)
16 (1) 48 (4)
62 (1)
46 (1)
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FIG. 1. Electron micrograph of human melanoma xenograft, HX41( x 6,800). The cells are mono-
nuclear and the central cell has two nucleoli. Its cytoplasm contains numerous melanosomes at
various stages ofdevelopment. The inset ( x 57,450) shows a melanosome containing relatively little
formed melanin but classical periodic melanofilaments.
tumour of unknown origin, HX49, were
examined with the electron microscope.
HX41 showed ultrastructural features
typical of malignant melanoma (Fig. 1).
Cells were mononuclear with 1-2 nucleoli,
and the cytoplasm contained a range of
melanosomes, some of classical, elliptical
appearance with distinctive periodicity of
the melanofilaments. Melanin granules
were seen. The type and quantity of
melanosomes and melanin granules varied
among the cells, but no separate sub-
groups of cells could be distinguished.
Darkly stained cells with long filamentous
processes were interspersed amongst the
melanoma cells, and they contained phago-
cytic vacuoles. These cells were thought to
be macrophages.
HX47 also showed features typical of
malignant melanoma, with numerous
melanosomes. However, the melanosomes
were more abnormal than those seen in
HX41, without the classical elliptical
shape or internal filamentous structure.
Melanin granules and melanosomes were
less numerous than in HX41, and some
cells contained few or none. Cells were
again heterogeneous in terms of melanin
content, but no distinct sub-groups could
be established. Macrophages were also
seen in this tumour.
HX49 was quite different in ultra-
structure. No melanin or melanosomes
were seen, and cells were mononuclear,
uniform, and contained large amounts of
glycogen.
Karyotypes
All the melanoma xenografts, and
HX49 and 60, had human karyotypes.
The other ovarian tumour xenografts and
the uterine tumour xenografts have notHUMAN TUMOURS GROWN IN IMMUNOLOGICALLY DEPRIVED MICE
TABLE IV.-Karyotypes of human tumour
xenografts
Human
chromosomes
HX identified
Melanoma
34
40
41
42
45
46
47
50
42
56
Others
49
Ovarian Ca
60
+
+
+
+
Approximate
mode of
chromosome
count
51-55
44
46-50
66-70
Not counted
85-87
69
43
66-70
46-50
80
+ Not counted
been tested. Xenografts were aneuploid,
and 8/10 examined were hyperdiploid. The
approximate modal numbers are shown in
Table IV.
Immunefluorescence
The xenografted melanomas were in-
vestigated by immune fluorescence, and
human antigens were successfully demon-
strated in sections cut from fixed and em-
bedded tissues. It was not necessary to cut
frozen sections to obtain satisfactory
material for staining. Human tumour cells
were readily distinguished from mouse
stroma cells by this technique, but
accurate quantification was notpossible.
Growth rates
Volume growth curves were plotted for
some passages of each of the melanoma
and ovarian tumour xenografts. For all
the tumours adequately assessed, the
shape of the growth curves indicated pro-
gressively increasing volume-doubling
times, and no initial exponential phase
could be defined (Fig. 2). This general
shape was compatible with Gompertzian
growth curves but no mathematical
analysis was carried out.
As indications of the relative growth
rates of xenografts, the median"volume-
HX Passage
Melanoma
34 (a) 14
40 3
6
41 1
4
5
42 (b) 4
45 1
2
5
46 1
2
4
8
47 1
2
4
50 1
3
5
52 1
2
56 1
2
3
Ovarian
carcinoma
60
61
62
63
1
2
1
1
2
1
doubling time at a volume of 0 5 cm3
(-1 cm mean diameter) and the median
time to reach that volume were measured.
These are shown in Table V, where it can
be seen that the doubling times for the
melanoma xenografts ranged from 5 to 30
days. The ovarian xenografts have been
examined for fewer passages, with fewer
tumours per passage, but HX60, 61 and
63 grew more slowly than the melanoma
xenografts. HX60 and HX63 showed
an initial regression of the implanted
TABLE V. growthratesofhumanmelanoma
and ovarian carcinoma xenografts
Median
volume-
doubling time
at 0.5 cm3
(days)
9
13
26
(7)
6
115
7.5
(19)
20
11
4
5.5
6
5-5
8
6
5-5
20
(11)
10
(29)
(30)
(7*5)
10
11
15
(23)
(40 at 0 4 cm3)
(5)
(6)
(30)
Median
time to
reach
0 5 cm3
(days)
26
41
50
(33)
28
34
23
(46)
44
27
24
12-5
17-5
18
34
25-5
22-5
65
(23)
23-5
(81)
(124)
(67 5)
40
34
119
(68)
(80)
(15)
(32)
(135)
Figures in brackets based on < 5 tumours.
All tumours were grown s.c. on flanks except
(a) HX34 which was grown i.m. in hind legs.
(b) HX42 grew as very flat tumours. Volume
estimated from 1r/6 d3 is therefore particularly over-
estimated.
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FiG. 2.-Selected volume growth curves (a) Ovarian carcinoma HX6O, Passage 1. (b) Melanoma
HX52, Passage 1. (c) Melanoma HX47, Passage 1. (d) Melanoma HX47, Passage 4.
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tumours, followed by growth (Fig. 2). This
pattern of initial regression was not seen
in melanoma tumour xenografts.
There was an impression that HX45, 47
and 50grew more quickly in later passages,
whilst HX40 grew more slowly. However,
there was a large scatter in the data, so
the differences were tested for significance
by the Wilcoxon two-sample rank sum
test to compare the doubling times of
groups of tumours in each passage.
Passages were only included in this
analysis if data on the growth of more
than 5 individual tumours were available.
HX45 and 46 were shown to grow sig-
nificantly more quickly in the later
passages, in terms of doubling time at a
volume of 0 5 cm3 and in terms of the
time taken to reach 0 5 cm3 that volume
(P < 0.05). HX50 and 56 took significantly
less time to grow to a volume of 0 5 cm3
in later passages, but their volume-
doubling times were not significantly de-
creased. No significant changes occurred
for HX40, 41, 42, 46 or 52.
DISCUSSION
The success rates for the establishment
of transplantable xenograft lines from
metastatic melanoma, ovarian cancer and
uterine cancer in mice immune-depressed
by thymectomy, AraC treatment and 900
rad whole-body irradiation were as good
as those reported in other types of T-
deprived mice, or in nude, athymic mice
(Povlsen, 1976; Kullander et al., 1978;
Berenbaum et al., 1974). Metastatic melan-
oma appeared to produce a higher take
rate than metastatic ovarian cancer, but
the difference was not statistically sig-
nificant using a x2 test with Yates' correc-
tion for small numbers. Preliminary re-
sults in this laboratory with other histo-
logical types of cancer, including testicular
teratoma, oat-cell carcinoma of the
bronchus, colo-rectal carcinoma and pan-
creatic tumours, indicate these are also
quite readily established as transplantable
xenograft lines in mice immune-deprived
by thymectomy, AraC and irradiation
(unpublished observations by Mr Andrew
Shorthouse, Dr Derek Ragavan and Mr
John G(ibbs). These results suggest that
this method of immune deprivation may
prove at least as useful as irradiation with
marrow reconstitution for the growth of
human tumour xenografts, and it is also a
simpler procedure. However, it is known
that T-deprived mice may recover their
immune competence 6-8 weeks after
irradiation (Steel et al., 1978) which may
be a limitation in some types of experi-
ment.
Ascitic ovarian tumours were not suc-
cessfully xenografted in this study in 5
attempts. This observation is in keeping
with the findings ofKullander et al. (1978)
that solid ovarian tumours grew as xeno-
grafts in nude mice but that cell suspen-
sions from these tumours and ascitic
ovarian tumours were much less successful.
Whether these results are due to poor
viability of the ascitic cells or to the
presence oflarge numbers ofinflammatory
cells is unclear.
The data suggest that the xenografts
here described maintained many import-
ant biological characteristics of human
cancer through serial passage. All retained
their human karyotypes and human
antigens. It is known that subtle changes
in karyotype may occur with serial xeno-
graft passage (Reeves & Houghton, 1978)
but detection of these requires the use of
banding techniques which were not used
in the present studies.
Histologically the xenografted tumours
resembled their original tumours, apart
from changes in the stromal content. The
stroma was shown to be of mouse origin in
the immuno-fluorescence studies. In the
endometrial adenocarcinomas ofthe uterus
there seemed to be a tendency for loss of
differentiation with serial passage. This
tendency to differentiate has also been
seen in a testicular teratoma xenograft
during serial passage, using immuno-
peroxidase staining for HCG and measure-
ment of HCG in mouse serum (Selby et al.,
1979). However, other workers have not
found loss of differentiation with passage
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(Houghton & Taylor, 1978a; Sharkey et
at., 1977).
Two of the melanoma xenografts lost
pigmentation during serial passage, as has
previously been observed (Mukherji et al.,
1974; Shimosato et al., 1976). The sig-
nificance of this change is not certain. It
could represent selection of a sub-popula-
tion of amelanotic cells or a phenotypic
variation due to the growth environment
of the cells. Since pigment production is a
differentiated function of melanocytes,
loss of this may represent a loss of
differentiation similar to that seen in the
uterine carcinomas and in the testicular
teratoma.
The ultrastructure of the melanoma
xenografts was similar to that described
by other authors for malignant melanoma
(Hunter et al., 1978) and classical melano-
somes were seen. However, the original
biopsies of these tumours were not ex-
amined by electron microscopy, so direct
comparison is not possible.
The measurements of growth rates sug-
gested that the melanoma xenografts grew
more quickly than in the patients. Volume-
doubling times of melanoma lung meta-
stases are of the order of 50 days (Steel,
1977). However, the lung metastases
measured were usually larger than 05 cm3,
and their growth may have slowed if they
grew according to Gompertzian growth
curves. The data on the ovarian tumour
xenografts in the present study are much
less complete and data from clinical
measurements are also scanty, probably
because lung metastases ofovarian carcin-
omas are unusual. Comparisons for the
ovarian carcinomas are therefore probably
not worthwhile. A tendency for xeno-
grafted tumours to increase in volume
more quickly than tumours in situ has
been described in other tumour types
(Lamerton & Steel, 1975).
Some of the melanoma xenografts
appeared to grow more quickly in later
passages, and this has been previously
reported in some xenografted tumours of
colo-rectal cancer (Houghton & Taylor,
1978b) and stomach cancer (Takahashi
et al., 1977). This increase in growth rate
with serial passage has been attributed to
a decrease in cell loss rather than to an
increase in cell proliferation within the
tumours (Lamerton & Steel, 1975;
Houghton & Taylor, 1978b). This explana-
tion would not be supported by the obser-
vation in the present study that mitotic
frequency increased with passage in most
of the tumours studied. However, mitotic
index is a notoriously unreliable measure-
ment, and confirmation of this would re-
quire more extensive studies of the cell-
proliferation kinetics of these tumours.
This study has shown that the thym-
ectomized, AraC-pretreated and irradiated
mouse can readily be used to establish a
series of human tumour xenografts, of at
least some histological types. These
tumours appeared to retain the charac-
tersistics of human tumours to a substan-
tial extent. However, some changes were
observed in degree of differentiation, pig-
mentation, growth rate and mitotic fre-
quency, and these emphasise the need for
careful assessment ofxenografted tumours
when they are used as models of human
cancer.
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